In July 2010, the ministry of higher education and research and the ministry of Health launched a call for proposal for a total of 850 million euros dedicated to hospital-university institutes (I.H.U) in the context of the “future investments” program.
This call intended to label world-class centers to strengthen France’s attractiveness in medical and scientific research.
An IHU is an institute of excellence, where the best public and private teams come together to build the future of medicine with the aim to conduct innovative research for patient’s benefit.
The Paris translational neuroscience institute leaded by ICM, with the support of its public partners , Sorbonne University, INSERM, CNRS and AP-HP, was one of the six projects selected for its exceptional quality.
These major scientific and medical findings result from the multi-disciplinary and business model promoted by ICM, which received the “University Hospital Institute” label in 2012.
On January 1st 2018, ICM and the foundation of scientific cooperation of IHU merged. Operating budget, actions, teams, achievements and hope were brought together for stronger coherence and a louder voice for the institute’s scientific and medical project.
Four pillars are at the heart of major projects that will help meet tomorrow’s challenges: to accelerate our understanding of the brain, and to revolutionize the way we treat patients: fundamental and translational research, technologic transfer, and commitment to education.
To have the power to rise to this challenge in the close future, we must strengthen our efforts, develop new skills, and keep on bringing innovation in our research.
This will be possible thanks to partnerships both private and public, which are major contributors in both our success and to the future of neuroscience.